Primary Care Clinics in Union, MO Accepting Medicare
6 Primary Care Clinics found. Showing 1 - 6
 Composite Rehab & Chiropractic Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 10 Hi Line Dr, Union, MO 63084 Phone: 636-221-7471 |
Compass Health, Inc Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 500 Clark Ave, Union, MO 63084 Phone: 844-853-8937 |
Patients First Health Care Llc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 97 Saint Andrews Dr, Union, MO 63084 Phone: 636-583-2946 Fax: 636-583-6131 |
Aspire Internal Medicine, L.l.c. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 302 Us Highway 50 W, Suite A, Union, MO 63084 Phone: 636-583-8555 Fax: 636-583-8559 |
Union Clinic Clinic/Center - Primary Care Medicare: Not Enrolled in Medicare Practice Location: 1780 Old Us Highway 50 E, Suite 102, Union, MO 63084 Phone: 636-583-8686 Fax: 636-583-1765 |
Compass Health Clinic/Center - Federally Qualified Health Center (FQHC) Medicare: Medicare Enrolled Practice Location: 1780 Old Hwy 50 E, Suite 102, Union, MO 63084 Phone: 636-584-0859 Fax: 636-583-2885 |
News Archive
Brain shapes normal body patterning much earlier than previously thought
The brain plays an active and essential role much earlier than previously thought, according to new research from Tufts University scientists which shows that long before movement or other behaviors occur, the brain of an embryonic frog influences muscle and nerve development and protects the embryo from agents that cause developmental defects.
Combination therapy restores skilled use of limb in rodent model
After the acute treatment window closes, the only effective treatment for stroke is physical/occupational therapy. Now scientists from Children's Hospital Boston report a two-pronged molecular therapy that leads to significant recovery of skilled motor function in a rat model of stroke.
New book traces history of child abuse policy in the U.S.
Black children are removed from their families at much greater rates than any other race or ethnicity in this country.
FDA approves Mylan's ANDA for generic Catapres-TTS
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 7 days ago